Ge Long Hui A P P·2025-12-02 10:12Core Viewpoint - Fosun Pharma's subsidiary, Suzhou Er Ye Pharmaceutical, has received acceptance for the drug registration application of sodium heparin injection by the National Medical Products Administration, indicating progress in the company's drug development pipeline [1]. Group 1: Drug Information - The sodium heparin injection is a self-developed chemical drug by the group [1]. - The drug is intended for multiple uses, including the prevention and treatment of venous thrombosis and pulmonary embolism, as well as for patients at risk of thromboembolic diseases due to major surgeries [1]. - Additional applications include treatment for atrial fibrillation with embolism, acute and chronic consumptive coagulopathy, and as an anticoagulant in various medical procedures such as blood transfusions and dialysis [1].